Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...

A TV commercial that the telehealth company Hims & Hers Health (NYSE:HIMS) is planning to run during the upcoming Super Bowl LIX coverage to promote its compounded weight loss products has drawn ...

Shares of Hims & Hers Health (NYSE:HIMS) rallied to reach an all-time high on Friday as the telehealth firm is set to debut its controversial TV commercial 'Sick of the System' during the upcoming ...

Exclusive: ASA calls number of parallel probes ‘significant’ and describes tackling issue as ‘priority’ after it issued ...

Amy Schumer has revealed she stopped using diabetes drug Ozempic for weight-loss after it left her 'bedridden'.

Hims & Hers stock price continues to fire on all cylinders this year and is hovering near its highest level on record. It has ...

People have been using Ozempic to lose weight - which its developer Novo Nordisk has warned against (Getty Stock Image) Advert "This is due to there being a high amount of fat in the buttocks and can ...

"Novo Nordisk does not condone, suggest, or encourage misuse of any of our medicines outside of their approved indications. Ozempic (semaglutide injection) is not licensed for the treatment of weight ...

Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

Novo Nordisk's U.S.-listed shares rose 5% in intraday trading after the Ozempic and Wegovy maker's better-than-estimated ...

Shortly after Hims & Hers aired its controversial Super Bowl ad promoting its compounded GLP-1 offerings, Novo Nordisk has ...